Company EKF Diagnostics Holdings plc

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 11:35:20 2024-04-24 am EDT			5-day change	1st Jan Change
27.75 ^GBX	+0.54%		+1.83%	-12.32%

Apr. 11	Onward Opportunities' small-cap strategy yields solid results in 2023	AN
Mar. 20	EKF Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Business Summary

EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.

Number of employees: 356

Sales per Business

GBP in Million	2022	Weight	2023	Weight	Delta
Diagnostic Instruments, Reagents and Ancillary Products 100.0 %	67	100.0 %	53	100.0 %	-21.05%

Sales per region

GBP in Million	2022	Weight	2023	Weight	Delta
United States 49.7 %	37	55.3 %	26	49.7 %	-29.03%
Germany 42.0 %	24	36.3 %	22	42.0 %	-8.67%
Russia 6.8 %	4	6.3 %	4	6.8 %	-15.09%
United Kingdom 1.5 %	1	2.1 %	1	1.5 %	-42.57%

Managers

Managers	Title	Age	Since
Stephen Young DFI	Director of Finance/CFO	-	23-09-11
Julian Baines CHM	Chairman	59	09-11-25
Salim Hamir		-	-

Members of the board

Members of the board	Title	Age	Since
Christopher Mills BRD	Director/Board Member	72	16-04-07
Christian Rigg BRD	Director/Board Member	49	21-06-30
Julian Baines CHM	Chairman	59	09-11-25
Jennifer Winter BRD	Director/Board Member	64	22-01-31

Share class

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	454,930,564	430,555,885 ( 94.64 %)	1,200,000 ( 0.2638 %)	94.64 %

Shareholders

Name	Equities	%	Valuation
Harwood Capital LLP 28.95 %	131,361,844	28.95 %	46 M p
Liontrust Investment Partners LLP 11.99 %	54,419,493	11.99 %	19 M p
Gresham House Asset Management Ltd. (Investment Management) 8.868 %	40,235,939	8.868 %	14 M p
Link Fund Solutions Ltd. 7.495 %	34,005,884	7.495 %	12 M p
Schroder Investment Management Ltd. 5.401 %	24,506,709	5.401 %	9 M p
Lombard Odier Asset Management (Europe) Ltd. 4.848 %	21,998,711	4.848 %	8 M p
Stockinvest Ltd. 4.202 %	19,065,000	4.202 %	7 M p
Chelverton Asset Management Ltd. 3.416 %	15,500,000	3.416 %	5 M p
Octopus Investments Ltd. 2.171 %	9,849,414	2.171 %	3 M p
Jarvis Investment Management Ltd. 1.599 %	7,255,000	1.599 %	3 M p